Associations of Fas (CD95), tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), and biochemical manifestations in elderly persons

Clinica Chimica Acta

Volumn 365, Issue 1-2, 2006, Pages 113-118

  Choi, Jong Weon ^a  

^a Inha University Hospital   (South Korea)

Author keywords

Apoptosis; Biochemical parameters; Fas (CD95); Tumor necrosis factor (TNF) related apoptosis inducing ligand (TRAIL)

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FAS ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; URIC ACID;

ADULT; AGED; AGING; APOPTOSIS; ARTICLE; BIOCHEMICAL COMPOSITION; BLOOD ANALYSIS; CHEMICAL ANALYSIS; CHEMICAL PARAMETERS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

AGED; ANTIGENS, CD95; APOPTOSIS REGULATORY PROTEINS; BLOOD CHEMICAL ANALYSIS; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTEIN BINDING; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 32044473277     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.08.004     Document Type: Article

References (25)

1. A.H. Wyllie Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview Cancer Metastasis Rev 11 1992 95 103
2. S.J. Webb, D.J. Harrison, and A.H. Wyllie Apoptosis: an overview of the process and its relevance in disease Adv Pharmacol 41 1997 1 34
3. F. Leithauser, J. Dhein, and G. Mechtersheimer Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells Lab Invest 69 1993 415 429
4. T. Suda, T. Takahashi, P. Golstein, and S. Nagata Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family Cell 75 1993 1169 1178
5. I. Cascino, G. Fiucci, G. Papoff, and G. Ruberti Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing J Immunol 154 1995 2706 2713
6. J.P. Sheridan, S.A. Marsters, and R.M. Pitti Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors Science 277 1997 818 821
7. G.C. Tsokos, and M. Tsokos The TRAIL to arthritis J Clin Invest 112 2003 1315 1317
8. T.M. Baetu, and J. Hiscott On the trail to apoptosis Cytokine Growth Factor Rev 13 2002 199 207
9. E. Knipping, K.M. Debatin, K. Stricker, B. Heilig, A. Eder, and P.H. Krammer Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias Blood 85 1995 1562 1569
10. W.W. Wong, J. Dimitroulakos, M.D. Minden, and L.Z. Penn HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 16 2002 508 519
11. M. Shimabukuro, Y.T. Zhou, M. Levi, and R.H. Unger Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes Proc Natl Acad Sci U S A 95 1998 2498 2502
12. T. Ichikura, T. Majima, T. Uchida, E. Okura, T. Ogawa, and H. Mochizuki Plasma soluble Fas ligand concentration: decrease in elderly men and increase in patients with gastric carcinoma Oncol Rep 8 2001 311 314
13. K. Ryo, Y. Kamogawa, and I. Ikeda Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure Am J Gastroenterol 95 2000 2047 2055
14. M. Rivero, J. Crespo, M. Mayorga, E. Fabrega, F. Casafont, and F. Pons-Romero Involvement of the Fas system in liver allograft rejection Am J Gastroenterol 97 2002 1501 1506
15. G. Shiota, K. Oyama, N. Noguchi, Y. Takano, S. Kitaoka, and H. Kawasaki Clinical significance of serum soluble Fas ligand in patients with acute self-limited and fulminant hepatitis Res Commun Mol Pathol Pharmacol 101 1998 3 12
16. L.H. Han, W.S. Sun, and C.H. Ma Detection of soluble TRAIL in HBV infected patients and its clinical implications World J Gastroenterol 8 2002 1077 1080
17. J.J. Cohen Programmed cell death in the immune system Adv Immunol 50 1991 55 85
18. K. Kawahito, Y. Misawa, and K. Fuse Transient rise in serum soluble Fas (APO-1/CD95) in patients undergoing cardiac surgery Artif Organs 24 2000 628 631
19. C.P. Reddy Avula, A. Muthukumar, and G. Fernandes Calorie restriction increases Fas/Fas-ligand expression and apoptosis in murine splenic lymphocytes FEBS Lett 458 1999 231 235
20. Y. Higami, I. Shimokawa, and M. Tomita Aging accelerates but life-long dietary restriction suppresses apoptosis-related Fas expression on hepatocytes Am J Pathol 151 1997 659 663
21. Y. Tazuke, R.A. Drongowski, I. Btaiche, A.G. Coran, and D.H. Teitelbaum Effects of lipid administration on liver apoptotic signals in a mouse model of total parenteral nutrition (TPN) Pediatr Surg Int 20 2004 224 228
22. H.K. Choi, S. Liu, and G. Curhan Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey Arthritis Rheum 52 2005 283 289
23. M.C. Perianayagam, S.L. Murray, and V.S. Balakrishnan Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure J Lab Clin Med 136 2000 320 327
24. N.M. Rajamannan, G. Sangiorgi, and M. Springett Experimental hypercholesterolemia induces apoptosis in the aortic valve J Heart Valve Dis 10 2001 371 374
25. W.A. Thomas, D.N. Kim, K.T. Lee, J.M. Reiner, and J. Schmee Population dynamics of arterial cells during atherogenesis: XIII. Mitogenic and cytotoxic effects of a hyperlipidemic (HL) diet on cells in advanced lesions in the abdominal aortas of swine fed an HL diet for 270-345 days Exp Mol Pathol 39 1983 257 270